Clinical Trial Update: Population Pharmacokinetics of Imatinib in CML Patients in Iran

View source ↗

Summary

Clinical trial update on the population pharmacokinetics of imatinib in chronic myeloid leukemia patients in Iran. The study is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib (imatinib)

Snippet

Sponsor: Kerman University of Medical Sciences | Conditions: Chronic Myelogenous Leukemia | Status: TERMINATED